EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis of Novel Benzofuran Spiro-2-Pyrrolidine Derivatives via [3+2] Azomethine Ylide Cycloadditions and Their Antitumor Activity

Bowen Pan iD, Tao Wang, Liangliang Zheng, Zhangchao Dong, Lijuan Liu, Xiongwei Liu, Tingting Feng, Ying Zhou, Yang Shi

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Bowen Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Thiosemicarbazones, Cycloaddition Reaction, Pyrrolidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Provincial Basic Research Program (Natural Science), the Guiyang City Science and Technology Plan Project, the Research Project on Traditional Chinese Medicine and Ethnic Medicine Science and Technology of Guizhou Provincial Administration of Traditional Chinese Med….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A synthetic strategy of a three-component spiro-pyrrolidine compound based on benzofuran via an [3+2] azomethine ylide cycloaddition reaction is reported herein. Under mild optimal conditions, this reaction can quickly produce potentially bioactive compounds with a wide range of substrates, high yield, and simple operation. The desired products were obtained with a yield of 74–99% and a diastereomeric ratio (dr) of >20:1. Subsequently, the inhibitory effects of the compounds on the cell viability of the human cancer cell line HeLa and mouse cancer cell line CT26 were evaluated. Compounds 4b (IC50 = 15.14 ± 1.33 µM) and 4c (IC50 = 10.26 ± 0.87 µM) showed higher antiproliferative activities against HeLa cells than cisplatin (IC50 = 15.91 ± 1.09 µM); compounds 4e (IC50 = 8.31 ± 0.64 µM) and 4s (IC50 = 5.28 ± 0.72 µM) exhibited better inhibitory activities against CT26 cells than cisplatin (IC50 = 10.27 ± 0.71 µM). The introduction of electron-donating substituents was beneficial to the inhibitory activities against cancer cells. Molecular docking simulations revealed that 4e and 4s may exert corresponding bioactivities by binding to antitumor targets through hydrogen bonds, providing a new approach for discovering spiro-heterocyclic antitumor drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsThiosemicarbazonesCycloaddition ReactionPyrrolidinesBenzofuransAzo CompoundsMolecular Docking SimulationHumansAnimalsMiceCell Line, TumorSpiro CompoundsCell ProliferationHeLa CellsStructure-Activity RelationshipMolecular StructureCell Survival

Stichwörter der Autor:innen

antitumor activitiesbenzofuranmolecular dockingspiro-pyrrolidine compound

Substanzen

azomethineAntineoplastic AgentsThiosemicarbazonesPyrrolidinesBenzofuransAzo CompoundsSpiro Compoundsbenzofuranpyrrolidine

Autor:innen und Institutionen

  • College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

ORCID-Profile: Bowen Pan

Förderung

  • Guizhou Provincial Basic Research Program (Natural Science)
  • the Guiyang City Science and Technology Plan Project
  • the Research Project on Traditional Chinese Medicine and Ethnic Medicine Science and Technology of Guizhou Provincial Administration of Traditional Chinese Med…
  • the High-level Innovative Talents of Guizhou Province
  • the State Key Laboratory of Natural and Biomimetic Drugs
  • Guizhou Province Innovation Talent Team Construction for the Efficient and Comprehensive Utilization of Unique Food and Medicinal Materials
  • Natural Science Research Project of Guizhou Department of Education
  • the projects of Guizhou province

Zitieren

APA

Pan, B., Wang, T., Zheng, L., Dong, Z., Liu, L., Liu, X., Feng, T., Zhou, Y., & Shi, Y. (2024). Synthesis of Novel Benzofuran Spiro-2-Pyrrolidine Derivatives via [3+2] Azomethine Ylide Cycloadditions and Their Antitumor Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413580

Vancouver

Pan B, Wang T, Zheng L, Dong Z, Liu L, Liu X, et al. Synthesis of Novel Benzofuran Spiro-2-Pyrrolidine Derivatives via [3+2] Azomethine Ylide Cycloadditions and Their Antitumor Activity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413580

BibTeX
@article{Pan2024,
  author = {Pan, Bowen and Wang, Tao and Zheng, Liangliang and Dong, Zhangchao and Liu, Lijuan and Liu, Xiongwei and Feng, Tingting and Zhou, Ying and Shi, Yang},
  title = {Synthesis of Novel Benzofuran Spiro-2-Pyrrolidine Derivatives via [3+2] Azomethine Ylide Cycloadditions and Their Antitumor Activity},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413580}
}
Kostenlos starten →